Previous 10 | Next 10 |
GERMANTOWN, Md. , Aug. 10, 2020 /PRNewswire/ -- Precigen ActoBio, an innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents and a wholly-owned subsidiary of Precigen, Inc. (Nasdaq: PGEN), today announced it has met the primary en...
GERMANTOWN, Md. , Aug. 6, 2020 /PRNewswire/ -- Precigen Triple-Gene, a clinical stage cardiovascular gene therapy company and majority-owned subsidiary of Precigen, Inc. (Nasdaq: PGEN), today announced six-month follow-up data from the Phase I trial of INXN-4001 (clinical tria...
GERMANTOWN, Md. , Aug. 3, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced it will release second quarter and first half 2020 financial re...
Precigen (NASDAQ: PGEN ) has filed a prospectus for a $500M mixed shelf offering. More news on: Precigen, Inc., , Healthcare stocks news, Read more ...
GERMANTOWN, Md. , June 22, 2020 /PRNewswire/ -- Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced preclinical data for its innovative investigational PRGN-3005 Ult...
GERMANTOWN, Md. , June 11, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari , PhD, President and CEO of Preci...
GERMANTOWN, Md. , June 4, 2020 /PRNewswire/ -- In light of the ongoing COVID-19 pandemic and taking into account guidance and protocols issued by public health and government authorities, Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the developmen...
Gainers: Genius Brands International (NASDAQ: GNUS ) +73% . More news on: Genius Brands International, Inc., Cassava Sciences, Inc., Secoo Holding Limited, Stocks on the move, , Read more ...
Evofem Biosciences (NASDAQ: EVFM ) -26% after pricing equity offering. More news on: Evofem Biosciences, Inc., Cellectar Biosciences, Inc., Reinsurance Group of America, Incorporated, Stocks on the move, , Read more ...
Gainers: CRWD +7.3% . MCHP +6.3% . CAKE +5.5% . AMSC +3.1% . LYFT +3.1% . More news on: CrowdStrike Holdings, Inc., Microchip Technology Incorporated, The Cheesecake Factory Incorporated, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-03 14:30:04 ET Stifel Nicolaus analyst issues MARKET OUTPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Market Outperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst co...
2024-06-03 14:30:03 ET JMP Securities analyst issues UNDERPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Underperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst consensus : B...
Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response PR Newswire – Phase 1/2 pivotal study met the primary safety and efficacy endpoints ...